Meyer, S. C. and Keller, M. D. and Chiu, S. and Koppikar, P. and Guryanova, O. A. and Rapaport, F. and Xu, K. and Manova, K. and Pankov, D. and O'Reilly, R. J. and Kleppe, M. and McKenney, A. S. and Shih, A. H. and Shank, K. and Ahn, J. and Papalexi, E. and Spitzer, B. and Socci, N. and Viale, A. and Mandon, E. and Ebel, N. and Andraos, R. and Rubert, J. and Dammassa, E. and Romanet, V. and Dolemeyer, A. and Zender, M. and Heinlein, M. and Rampal, R. and Weinberg, R. S. and Hoffman, R. and Sellers, W. R. and Hofmann, F. and Murakami, M. and Baffert, F. and Gaul, C. and Radimerski, T. and Levine, R. L.. (2015) CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms. Cancer Cell, 28 (1). pp. 15-28.
Full text not available from this repository.
Official URL: https://edoc.unibas.ch/62360/
Downloads: Statistics Overview
Abstract
Faculties and Departments: | 03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Myeloid Malignancies (Meyer S) |
---|---|
UniBasel Contributors: | Meyer, Sara C. |
Item Type: | Article, refereed |
Article Subtype: | Research Article |
e-ISSN: | 1878-3686 |
Note: | Publication type according to Uni Basel Research Database: Journal article |
Related URLs: | |
Identification Number: |
|
Last Modified: | 19 Nov 2018 17:46 |
Deposited On: | 19 Nov 2018 17:46 |
Repository Staff Only: item control page